(1)
Molecular Docking, Bioactivity, Adme, Toxicity Risks, and Quantum Mechanical Parameters of Some 1,2-Dihydroquinoline Derivatives Were Calculated Theoretically for Investigation of Its Use As a Pharmaceutical Active Ingredient in the Treatment of Multiple Sclerosis (MS). Prospect. Pharm. Sci. 2024, 22 (4), 168-187. https://doi.org/10.56782/pps.261.